The CREATE Act: increasing costs associated with the biotech industry?
A new law intended to promote collaborative research may end up costing the biotech industry more and inhibiting innovation.
Mills
Ann E
AE
Program in Ethics and Policy in Health Care, Center for Biomedical Ethics, University of Virginia School of Medicine, P.O. Box 800758, Charlottesville, Virginia 22908, USA. amh2r@virginia.edu
Chen
Donna T
DT
Gillon
John J
JJ
Tereskerz
Patti M
PM
D001709:Biotechnology / Q000191:economics / Q000331:legislation & jurisprudence*; D007373:Interinstitutional Relations; D010330:Patents as Topic / Q000331:legislation & jurisprudence*; D018581:Technology Transfer; D014481:United States